Cite
Discovery of a selective and biologically active low-molecular weight antagonist of human interleukin-1β.
MLA
Hommel, Ulrich, et al. “Discovery of a Selective and Biologically Active Low-Molecular Weight Antagonist of Human Interleukin-1β.” Nature Communications, vol. 14, no. 1, Sept. 2023, p. 5497. EBSCOhost, https://doi.org/10.1038/s41467-023-41190-0.
APA
Hommel, U., Hurth, K., Rondeau, J.-M., Vulpetti, A., Ostermeier, D., Boettcher, A., Brady, J. P., Hediger, M., Lehmann, S., Koch, E., Blechschmidt, A., Yamamoto, R., Tundo Dottorello, V., Haenni-Holzinger, S., Kaiser, C., Lehr, P., Lingel, A., Mureddu, L., Schleberger, C., … Bornancin, F. (2023). Discovery of a selective and biologically active low-molecular weight antagonist of human interleukin-1β. Nature Communications, 14(1), 5497. https://doi.org/10.1038/s41467-023-41190-0
Chicago
Hommel, Ulrich, Konstanze Hurth, Jean-Michel Rondeau, Anna Vulpetti, Daniela Ostermeier, Andreas Boettcher, Jacob Peter Brady, et al. 2023. “Discovery of a Selective and Biologically Active Low-Molecular Weight Antagonist of Human Interleukin-1β.” Nature Communications 14 (1): 5497. doi:10.1038/s41467-023-41190-0.